Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » Cancer Genetics Q2 Revenues Drop 5 Percent

Cancer Genetics Q2 Revenues Drop 5 Percent

Aug 14, 2020
|
staff reporter

NEW YORK – Cancer Genetics on Friday reported a 5 percent decrease in second quarter revenues, which it said was primarily due to the timing of discovery services studies.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

This Time, Novamax

Novamax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

New York's Own Review

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

Shortened Visas for Some Students

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

Science Papers Examine Y Chromosomes of Archaic Humans, Schistosomiasis Therapeutic Targets

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.

What's Popular?

In Business News

  1. Exact Sciences Stock Soars on New Data Around Pan-Cancer Liquid Biopsy Test

  2. Clear Labs Nanopore Sequencing Coronavirus Test Gets FDA Emergency Use Authorization

  3. Ionpath Closes $18M Series B Round

  4. Grail Deal Will Enable Illumina to Expand From Tech Innovator to Diagnostics Provider

    Premium

  5. FDA Grants Emergency Use Authorizations for Quadrant Biosciences, KimForest Coronavirus Tests

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.